Research Analysts Offer Predictions for ARTV Q1 Earnings
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings per share estimates for Artiva Biotherapeutics in a report issued on Monday, March 24th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.62) per share for the quarter. Wedbush has a “Outperform” rating […]
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) – Equities research analysts at Wedbush issued their Q1 2025 earnings per share estimates for Artiva Biotherapeutics in a report issued on Monday, March 24th. Wedbush analyst D. Nierengarten anticipates that the company will post earnings of ($0.62) per share for the quarter. Wedbush has a “Outperform” rating […]
